Medical Communications - the Next Big Thing?
The recent ‘PR war’ between pharmaceutical giant, Roche and the National Institute for Health and Care Excellence (NICE) over the latter’s rejection of the breast cancer drug, Kadcyla has shown how important the role of comms professionals has become in the life sciences sector.
“Drugs companies have moved from long-term development of big-hitter therapies to producing medicines that target very specific conditions,” says Lucinda Moores, Practice Director at corporate communications recruitment specialist, VMA Group. “This means more drugs coming onto the market faster and a higher rejection rate by bodies such as NICE because of budgetary constraints. We’re consequently likely to see more and more focus on shaping and communicating the case for these treatments, not just through conventional channels, but increasingly across public media.”
According to VMA Group’s research this is likely to dramatically increase the already high demand for medical communications professionals.
“We fully expect that the most senior and technical roles in medical communications will continue to be held by individuals with masters and PhDs in life sciences and even by trained medical doctors. However, increasing pressures in the area are also likely to mean that both corporations and agencies will need to draw in talent from other parts of the PR industry to provide support and wider communication skills. Medical communications is consequently set to be a magnet for some of the best comms talent available over the next few years.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance